GLP1R and cancer: Prior epidemiological studies have yielded conflicting results, with some suggesting effects on cancer risk and others reporting potential associations with worse outcomes in certain malignancies.11,12,13,14 Preclinical studies indicate GLP-1R signaling on immune cells can drive an immunosuppressive phenotype15,16,17 and has been linked to pro-survival pathways in other cellular contexts18,19.